Literature DB >> 17353051

Phage display of chelating recombinant antibody libraries.

Michael J Wright1, Mahendra P Deonarain.   

Abstract

High affinity and discriminating specificity are important parameters for any successful antibody based targeting strategy. We herein describe a system for the construction and subsequent selection of affinity-optimised chelating recombinant antibodies (CRAbs) from a randomised filamentous phage-display inter-scFv linker library. Using a simple, robust and highly degenerate tandem scFv cloning strategy a phage-display library of CRAbs with varied inter-scFv linkers was constructed and characterised. The library consisted of two single-chain Fvs (scFvs) of well characterised anti-lysozyme antibodies D1.3 and HyHEL-10(TF), specific for distinct non-overlapping epitopes, separated by flexible polypeptide linkers of varying lengths and sequences. The use of a stringent affinity-based selection strategy quickly led to the enrichment of CRAbs with a restricted set of linker lengths (16-21 amino acids) which agrees very closely with previously described crystal structure data, affinity measurements and mathematical modelling. This CRAb linker phage-display selection strategy is a widely applicable approach for the selection of very high affinity CRAbs for pairs of scFvs against potentially any target antigen, complementing the more arbitrary affinity maturation approaches based on random mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353051     DOI: 10.1016/j.molimm.2007.01.026

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.

Authors:  Alessandra Villa; Valeria Lovato; Emil Bujak; Sarah Wulhfard; Nadine Pasche; Dario Neri
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

3.  Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding.

Authors:  Nathan Scott; Omar Qazi; Michael J Wright; Neil F Fairweather; Mahendra P Deonarain
Journal:  Mol Immunol       Date:  2010-04-22       Impact factor: 4.407

4.  Gene therapy of malignant solid tumors by targeting erbB2 receptors and by activating T cells.

Authors:  Wang-Xiong Hu; He-Ping Chen; Kang Yu; Lu-Xi Shen; Chao-Yan Wang; Shi-Zhen Su; Wen-Jun Sui; Da-Ming Shan; Hong-Zhi Li
Journal:  Cancer Biother Radiopharm       Date:  2012-09-18       Impact factor: 3.099

5.  Linking Single Domain Antibodies that Recognize Different Epitopes on the Same Target.

Authors:  Richard H Glaven; George P Anderson; Dan Zabetakis; Jinny L Liu; Nina C Long; Ellen R Goldman
Journal:  Biosensors (Basel)       Date:  2012-02-01

6.  Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.

Authors:  Patrick Chinestra; Aurélien Olichon; Claire Medale-Giamarchi; Isabelle Lajoie-Mazenc; Rémi Gence; Cyril Inard; Laetitia Ligat; Jean-Charles Faye; Gilles Favre
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 7.  Antibody Engineering for Pursuing a Healthier Future.

Authors:  Abdullah F U H Saeed; Rongzhi Wang; Sumei Ling; Shihua Wang
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.